BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard Global Health Institute - ECPv6.5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Harvard Global Health Institute
X-ORIGINAL-URL:https://globalhealth.harvard.edu
X-WR-CALDESC:Events for Harvard Global Health Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20241015T120000
DTEND;TZID=UTC:20241015T130000
DTSTAMP:20260413T085414
CREATED:20241007T165504Z
LAST-MODIFIED:20241112T205833Z
UID:10000829-1728993600-1728997200@globalhealth.harvard.edu
SUMMARY:Arboviruses on the Rise: Mitigating the Threats from Dengue\, EEE\, Zika and More in a Changing World
DESCRIPTION:The growing threat of Dengue and other arboviruses\, such as Zika\, Chikungunya\, Yellow Fever\, and Eastern Equine Encephalitis (EEE)\, has become a critical public health concern\, particularly in tropical and sub-tropical regions\, where nearly 4 billion people are at risk\, including in the US. This webinar will convene leading experts in virology\, infectious diseases\, entomology\, and public health to discuss the rising frequency and severity of outbreaks. Panelists will explore the global spread of arboviruses\, and assess the effectiveness of current prevention and response measures\, including vector control and vaccine development. Special attention will be given to gaps in preparedness and the urgent need for coordinated international action\, particularly in the context of climate change\, urbanization\, and strained health infrastructure. \nThe event is free and open to the public. \nAbout our Speakers\n \nDr. Anoja Dheerasinghe\, MBBS\, MSc\, MD\, Medical Specialist in Public Health at the National Dengue Control Unit of the Ministry of Health\, Sri Lanka \nDr Anoja Dheerasinghe is a Medical Specialist in Public Health (Consultant Community Physician) at the National Dengue Control Unit\, Ministry of Health\, Sri Lanka. She received her MBBS from the University of Kelaniya and her Masters and Doctor of Medicine in Community Medicine from the University of Colombo\, Sri Lanka. Later\, she obtained her Master’s in Medical Entomology and Applied Parasitology from the Open University of Sri Lanka. Dr. Dheerasinghe is also a member of the Technical Advisory Group for Dengue Prevention and Control in Sri Lanka. Before her current position\, she worked as a Consultant Epidemiologist in the Epidemiology Unit in the Western Province\, Sri Lanka\, where she managed all communicable diseases\, including vector-borne diseases such as dengue\, malaria\, and filariasis. She also served as a medical doctor for the Anti-Malaria Campaign at the Ministry of Health of Sri Lanka during the pre-elimination phase. With over 25 years of experience\, she specializes in Neglected Tropical Diseases and malaria. \n  \n \nDr. Gabriela Paz-Bailey\, MD\, PhD\, MSc\, Chief of the Dengue Branch at Division of Vector Borne Diseases\, Centers for Disease Control and Prevention \nDr. Paz-Bailey is the Chief of the Dengue Brach\, Division of Vector Borne Diseases at the Centers for Disease Control and Prevention. She leads the development of research infrastructure in Puerto Rico\, to understand health disparities in the epidemiology of arboviruses and the impact of novel interventions. Dr. Paz-Bailey has done extensive work on evaluating new dengue vaccines as CDC lead for the ACIP Dengue Vaccines Workgroup. ACIP recently recommended the use of Sanofi Dengvaxia quadrivalent dengue vaccine in dengue endemic areas in the United States. This vaccine poses unique programmatic challenges to implementation in requiring pre-vaccination screening for prior dengue infection\, and messaging regarding its higher risks for dengue severe disease if dengue naives are vaccinated. Two other promising dengue candidate vaccines are in Phase Ill trials. Dr. Paz-Bailey will lead the review of the benefits and harms to present draft recommendations to ACIP. \n  \n \nDr. Amir Mohareb\, MD\, Director\, Research Program on Humanitarian Action\, Global Migration\, and Infectious Diseases at the Mass General Center for Global Health \nDr. Amir Mohareb is an Infectious Diseases physician at Massachusetts General Hospital and Harvard Medical School. His clinical and research interests center around HIV\, viral hepatitis\, tropical diseases\, and vaccine-preventable infections. His work examines the health effects of migration and forced displacement\, with the overall aim of improving clinical\, public health\, and social policies. He investigates the interaction between human-made and natural humanitarian emergencies and infectious diseases\, with an emphasis on vaccine-preventable infections. He uses epidemiology and simulation modeling to better understand how (1) complex humanitarian emergencies contribute to the risk for communicable diseases\, especially among people who are displaced\, and (2) how infectious diseases can complicate the clinical and public health response to humanitarian emergencies. \n  \nSpeakers will share their own perspectives; they do not speak for the university.
URL:https://globalhealth.harvard.edu/event/arboviruses-on-the-rise/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/Arbovirus-Special-Event-Promo-Image-900x600px-no-QR-Code-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241008T120000
DTEND;TZID=America/Halifax:20241008T124500
DTSTAMP:20260413T085414
CREATED:20240910T153534Z
LAST-MODIFIED:20241112T211448Z
UID:10000819-1728388800-1728391500@globalhealth.harvard.edu
SUMMARY:Hunger\, Food Security\, and the Race to Produce New Seeds for a Climate-Changed World
DESCRIPTION:Many of the world’s most productive agricultural regions are increasingly vulnerable to extreme droughts\, floods\, and unpredictable weather patterns. As climate change forces farmers to migrate and adapt\, the ripple effects on global food systems and public health will be felt for decades. In response\, crop research centers are racing to develop new seed varieties that can withstand these harsh conditions. Drawing on lessons from the mid-twentieth century efforts to rapidly increase food production\, this session explores the urgent need for innovation in food production\, highlighting the long-term impacts on the environment\, health\, and food security. Dr. Gabriela Soto Laveaga will discuss how this race for resilience will shape the future of global health and well-being. Dr. Megan Murray will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n \nGabriela Soto Laveaga\, PhD\, MA\, Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University \nGabriela Soto Laveaga is Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University. Her award-winning first book Jungle Laboratories: Mexican Peasants\, National Projects and the Making of the Pill narrated the impact of the search for medicinal plants at the local\, national\, and global level. Her award-wining articles have ranged from examining the role of indigenous midwives in the Mexican healthcare system\, the use of soap operas to deliver public health messaging\, Latin American innovation in science and medicine\, and how we narrate histories of science outside of so-called centers of innovation. She is completing two book manuscripts: one on doctors as agents of social unrest and her third book which examines agricultural science exchange between India and Mexico. She has been a fellow at the Institute of Advanced Study at Princeton\, held the Dibner Distinguished fellowship in History of Science and Technology at the Huntington Library\, among other awards. Most recently she was elected to the Academia Mexicana de la Historia\, one of the highest honors for a historian of Mexico\, especially one outside of the country. She is also a past recipient of the Everett Mendelsohn Excellence in Graduate Mentoring Award. \n  \n \nMegan Murray\, ScD\, MD\, Ronda Stryker and William Johnston Professor of Global Health\, Harvard Medical School; Director of Research\, Global Health & Social Medicine\, Harvard Medical School \nMegan Murray is an epidemiologist and an infectious disease physician\, with over 25 years of experience studying tuberculosis and other infectious diseases. She received her MD from Harvard Medical School in 1990 and completed her residency in internal medicine and a fellowship in Infectious Disease at Massachusetts General Hospital. She received her ScD in Epidemiology from the Harvard School of Public Health in 2000. She currently serves as the Ronda Stryker and William Johnston Professor of Global Health and Social Medicine at Harvard Medical School and as a Professor of Epidemiology at the Harvard Chan School of Public Health. \nDr. Murray’s research focuses on social\, host and pathogen specific determinants of TB infection\, disease and treatment outcomes. She studies nutritional risk factors for TB infection and disease\, including macronutrients status and the role of Vitamins A\, E and D. She uses bacterial and human genetic and genomic tools to identify variants of interest and their role in TB. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/hunger-food-security-and-the-race-to-produce-new-seeds/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/09/Soto-RI-Speaker-Series-Mailchimp-Image-Template-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240927T090000
DTEND;TZID=UTC:20240927T094500
DTSTAMP:20260413T085414
CREATED:20240912T183259Z
LAST-MODIFIED:20241001T170814Z
UID:10000820-1727427600-1727430300@globalhealth.harvard.edu
SUMMARY:Forging Bidirectional Accompaniment in Global Health
DESCRIPTION:Join us for an insightful conversation on the concept of bidirectional accompaniment in global health with Dr. Joia Mukherjee\, Director of the Master of Medical Sciences in Global Health Delivery program and Global Medical Education and Social Change program at Harvard Medical School and Chief Medical Officer at Partners In Health alongside Dr. Anatole Manzi\, Deputy Chief Medical Officer of Learning and Quality Health Systems Strengthening at Partners in Health. This session will delve into the profound definition of accompaniment as articulated by Paul Farmer: “Being present on a journey with someone and committing to that person’s well-being.  Accompaniment is both an objective that is set at the beginning of a task and a mode of follow through.”  \nDrs. Mukherjee and Manzi will illustrate how bidirectional accompaniment is a cornerstone of success in global health practice\, where sharing new skills\, tools\, and approaches is not an optional endeavor\, but a crucial element. The pair will provide concrete examples of how this concept plays out in global health\, defining exactly what it looks like as well as what it does not. Dr. Louise Ivers\, Faculty Director of the Harvard Global Health Institute\, will moderate the discussion. \nThe event is free and open to the public. \nRegister \nAbout the Speakers\n \nJoia S. Mukherjee\, MD\, MPH\, Chief Medical Officer\, Partners In Health\, Director and Advisory Dean\, F.W. Peabody Society\, Director\, Master in Medical Science in Global Health Delivery\, Harvard Medical School; Associate Professor of Medicine\, Brigham and Women’s Hospital \nDr. Mukherjee is an associate professor of medicine in the Division of Global Health Equity\, Department of Medicine\, Brigham and Women’s Hospital\, and associate professor of global health and social medicine at Harvard Medical School. She directs the Master of Medical Sciences in Global Health Delivery program and the Program in Global Medical Education and Social Change. She teaches infectious disease\, global health delivery\, and human rights to health professionals and students from around the world. Dr. Mukherjee has helped to create new residency and fellowship training programs for Rwandan and Haitian physicians as well as global health residencies and fellowships for US trainees at Harvard and other American universities. \nDr. Mukherjee’s scholarly work focuses on the provision of health as a human right and on the design\, implementation\, and evaluation of comprehensive health care in resource-poor settings. \nDr. Mukherjee is a graduate of the University of Minnesota Medical School\, trained in infectious disease\, internal medicine\, and pediatrics at the Massachusetts General Hospital\, and has an MPH from the Harvard School of Public Health. Since 2000\, Dr. Mukherjee has served as the chief medical officer of Partners In Health\, a nonprofit medical organization focused on reducing global health disparities by strengthening health systems through public sector support and community-based programs. She provides strategic guidance on the implementation of clinical programs at PIH’s sites in Haiti\, Rwanda\, Malawi\, Lesotho\, Peru\, Mexico\, Russia\, Sierra Leone\, and Liberia and has served as an expert consultant for the World Health Organization and Ministries of Health of HIV\, TB\, health systems strengthening and health workforce development. \n  \nDr. Mukherjee also serves on the board of directors for Village Health Works (Burundi) and Muso (Mali) and the Institute for Justice and Democracy in Haiti. She advises various grassroots organizations throughout the developing world in their work to deliver health care with a human rights-based approach to the poorest of the poor. \n  \n \nAnatole Manzi\, PhD\, MPhil\, MPH\, Deputy Chief Medical Officer\, Learning and Quality Health Systems Strengthening\, Partners in Health \nAnatole Manzi serves as the Deputy Chief Medical Officer at Partners In Health (PIH)\, where he oversees learning and quality health systems strengthening. In this role\, Dr. Manzi collaborates with PIH-supported countries to develop and implement strategies for quality improvement and health systems strengthening. His work focuses on integrating quality management with clinical practice through innovative solutions. Additionally\, he manages relationships with various partners\, including academic and non-academic global health organizations\, to support the design\, implementation\, evaluation\, and dissemination of best practices in patient safety and systems improvement. \nPreviously\, Dr. Manzi held the positions of Director of Clinical Practice and Quality Improvement and Director of Global Learning and Training at PIH. In these roles\, he led the organization-wide education and training strategy\, including the development and standardization of guidelines and tools essential for delivering high-quality care in PIH-supported countries. He also designed and directed the Mentorship\, Enhanced Supervision for Healthcare and Quality Improvement (MESH-QI) program\, an innovative health systems strengthening approach that significantly improved core clinical domains such as maternal and newborn health\, infectious diseases\, and non-communicable diseases. \nDr. Manzi has served on various technical working groups at the World Health Organization (WHO) and the Rwandan Ministry of Health. As an implementation scientist\, his research focuses on developing\, adapting\, and validating healthcare quality measurement and improvement metrics in resource-limited settings. He is an Assistant Professor at the University of Global Health Equity and a Lecturer at Harvard Medical School. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/forging-bidirectional-accompaniment-in-global-health/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/09/9-27-24-Coffee-Sessions-Mailchimp-Image-900x600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240910T120000
DTEND;TZID=America/Halifax:20240910T124500
DTSTAMP:20260413T085414
CREATED:20240827T142350Z
LAST-MODIFIED:20240828T150140Z
UID:10000249-1725969600-1725972300@globalhealth.harvard.edu
SUMMARY:Impact of Arbovirus Infection on Pregnancy
DESCRIPTION:  \n \nThe adverse impact of Zika (ZIKV)\, dengue (DENV)\, and chikungunya (CHIKV) virus infection in pregnancy has been recognized in Latin America and Asia but is not well studied in Africa. Although originally discovered in sub-Saharan Africa\, the non-specific clinical presentation of arbovirus infection may have hampered our detection of adverse clinical outcomes and outbreaks. This prospective study of arbovirus infection in pregnant women in north-central Nigeria sought to characterize the prevalence of acute arbovirus infection and determine the impact on pregnancy and infant outcomes. \nDr. Phyllis Kanki will talk about her research on this important topic and attendees are encouraged to join the discussion by sending us their questions. Dr. Louise Ivers will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n\nPhyllis Kanki\, DVM\, DSc\, Mary Woodard Lasker Professor of Health Sciences \nPhyllis Kanki is the Mary Woodard Lasker Professor of Health Sciences at the Harvard T. H. Chan School of Public Health. She has worked in West Africa since 1984\, where her research in Senegal provided the initial characterization of HIV-2\, demonstrated reduced virulence\, transmission and progression to disease and interactions with HIV-1 subtypes. In 2000\, she founded the AIDS Prevention Initiative in Nigeria (APIN)\, supported by the Bill & Melinda Gates Foundation modeled after the Senegal research collaboration. She led Harvard’s President’s Emergency Plan for AIDS Relief (PEPFAR) program supporting prevention\, care and HIV antiretroviral therapy for over 200\,000 patients in Nigeria\, Botswana\, and Tanzania (2005-2013). In West Africa\, following epidemics of Ebola (EBOV) and Zika virus (ZIKV)\, she documented the multi-decade presence of ZIKV\, demonstrating the endemicity of this unique arbovirus in the region. She described the longevity\, specificity and cross reactivity of T cell responses to ZIKV and DENV and characterized the T cell responses in survivors and exposed health care workers from the 2015 Nigeria EBOV outbreak. She has just completed a 3 year study of ZIKV\, dengue and Chikungunya virus infection in pregnant women and documenting associated microcephaly and other birth abnormalities. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-speaker-series-2024-09-10/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/08/Phyllis-Kanki-RI-Speaker-Series-Promo-Image-900-x-600-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240726T090000
DTEND;TZID=UTC:20240726T094500
DTSTAMP:20260413T085414
CREATED:20240618T143255Z
LAST-MODIFIED:20240709T150838Z
UID:10000557-1721984400-1721987100@globalhealth.harvard.edu
SUMMARY:A Partnership for a Shared Vision of Equity in Global Health
DESCRIPTION:Dr. Jessica Haberer of Harvard Medical School and Professor Yap Boum II of the Institute Pasteur of Bangui will discuss their decade-long collaboration promoting global health equity through advocacy\, mentorship\, and empowering communities. They will present their new project\, “The Village”\, an AI digital platform connecting researchers\, clinicians and institutions worldwide without barriers. By facilitating cross-border connections\, The Village aims to decolonize global health by giving communities access to diverse resources and empowerment to develop innovative\, locally led solutions. Drs. Haberer and Boum will reflect on the lessons learned from their long-standing partnership\, including the key strategies and approaches that helped them to collaborate effectively and overcome challenges together. Dr. Louise C. Ivers will moderate the conversation. \nThe event is free and open to the public. \nRegister \nAbout the Speakers\n \nJessica Haberer\, MD\, MS\, Professor of Medicine\, Harvard Medical School; Director of Research\, Massachusetts General Hospital Center for Global Health \nJessica Haberer\, MD\, MS is a Professor of Medicine at Harvard Medical School and the Director of Research at the Massachusetts General Hospital Center for Global Health. Her research primarily focuses on the prevention and treatment of HIV and tuberculosis and involves diverse methodologic approaches and disciplines\, including clinical epidemiology\, behavioral science\, implementation science\, data science\, mHealth\, mathematical modeling\, and ethics. Current collaborations are ongoing in Uganda\, Kenya\, and South Africa. Dr. Haberer is also committed to active mentorship\, promotion of diversity in the work force\, and equity in global health research partnerships. She is the co-founder of Homegrown Solutions for Health and The Village – an AI-driven digital platform to promote equitable career development and collaboration in global health. \n  \n \nYap Boum II\, PhD\, MPH\, MBA\, Executive Director\, Institute Pasteur of Bangui \nProfessor Yap Boum II is Executive Director of the Institute Pasteur of Bangui in Central Africa Republic. He is the former Regional Representative for Epicentre in Africa\, which he joined in 2008 after obtaining his master’s in microbiology and a PhD in Biology at Université Paris-Sud. He holds an MPH from the Liverpool School of Tropical Medicine\, and an MBA from University of Cape Town. \nProfessor Boum has implemented several research projects including clinical trials on tuberculosis\, malaria\, NTDs\, Ebola\, COVID-19 in Uganda\, Guinea\, DRC and Cameroon among others. This work has earned him more than 130 scientific publications. For the last two years he has been involved in the COVID-19 response as the Chief of Operations of Public Health Emergency Operating Center in Cameroon. \nBoum is the co-founder of Kmerpad\, a nonprofit that developed washable sanitary pads to empower women and allow them to fully participate in their education and limit waste. He has also co-founded iDocta\, a digital platform that brings healthcare services to the community. Professor Boum started Homegrown Solutions for Health (HS4Health) to promote the creation of a critical mass of Africans to find homegrown and innovative solutions toward addressing the social and health challenges Africa faces. The Village digital platform is the development of HS4Health that will break barriers and connect scientists to transform and decolonize global health. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/shared-vision/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/06/7-26-2024-Coffee-Sessions-Promo-Image-900x600px-no-QR-code.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240628T090000
DTEND;TZID=UTC:20240628T094500
DTSTAMP:20260413T085414
CREATED:20240611T195813Z
LAST-MODIFIED:20240620T211051Z
UID:10000556-1719565200-1719567900@globalhealth.harvard.edu
SUMMARY:Oral Histories\, Microsensors\, and Parametric Insurance: When Poor Women Workers Drive the Research Agenda
DESCRIPTION:SEWA members\, Manshi Shah and Kapilaben Vankar\, in conversation with Satchit Balsari\, will describe how the 3 million-strong Self Employed Women’s Association has approached academic partnerships. Over 50 years\, SEWA has partnered with a range of researchers from India and abroad; and established educational programs and exchanges with local academic institutions. Harvard faculty have collaborated with SEWA for over two decades. In this HGHI Coffee Session\, the speakers will describe how a research project examining SEWA’s response to the pandemic evolved into a multi-city traveling exhibition\, that will travel from Harvard to New York and DC and then the west coast. They will share how SEWA’s members\, most at-risk to extreme heat\, are partnering with researchers to inform cutting age climate adaptation products including the world’s first-ever parametric insurance product to protect wages when it’s too hot to work. The speakers will present their vision for what meaningful research partnerships between academic institutions and communities can look like. \n  \nAbout our Speakers\n \nSatchit Balsari\, MD\, MPH\, Associate Professor\, Emergency Medicine\, Harvard Medical School and Beth Israel Deaconess Medical Center; Department of Global Health and Population\, Harvard T.H. Chan School of Public Health \nDr. Satchit Balsari is Associate Professor in Emergency Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center; and in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. Dr. Balsari’s research and teaching are focused on complex humanitarian emergencies and digital health implementation science in resource-poor settings. He has worked with populations affected by disaster\, war and the COVID-19 pandemic in Iraq\, South Sudan\, Jordan\, Haiti\, Puerto Rico and across South Asia. In the most vulnerable communities in the world\, his team has leveraged cutting-edge digital tools and citizen science to advance public health planning\, advocacy\, and response. The Balsari Lab collaborates directly with populations in distress\, humanitarian response agencies\, civil society organizations\, governments\, and international agencies\, to reduce the information asymmetry that threatens to exclude the poor and disadvantaged from decisions that will impact their lives. Dr. Balsari co-directs CrisisReady.io\, a research-response platform that builds data-driven decision tools for local communities and response agencies affected by disasters globally. Dr. Balsari is founding director of the tri-institute Climate and Human Health fellowship at Harvard\, leads the climate platform at the Lakshmi Mittal and Family South Asia Institute\, and is co-investigator on the Salata Institute’s inaugural interfaculty cluster grant on Climate Change Adaptation in South Asia. He recently has curated an exhibition\, Hum Sab Ek\, which is based on his research on the impact of the COVID-19 pandemic on the 2.9 million-strong Self Employed Women’s Association (SEWA)\, and its members’ response to it. Prior signature initiatives include EMcounter (a customizable\, portable digital surveillance tool\, the latest iteration of which was used at the world’s largest mass gathering\, the Kumbh Mela in India) and Voices\, a crowd-sourced\, online disaster response analysis tool. In 2018\, in collaboration with Professor Caroline Buckee (Epidemiology)\, he co-led the Hurricane Maria Mortality Study. \n  \n \nMansi Shah\, Senior Technical Coordinator\, Rural Economic and Development; Program Manager\, Future of Work\, SEWA  \nMansi Shah has spent 13 years as the Senior Technical Coordinator in Rural Economic and Development sector for SEWA and is a program manager for the Future of Work activities at SEWA. Under the guidance of SEWA’s director Reema Nanavaty (Commissioner\, ILO’s Global Commission on Future of Work)\, Mansi has orchestrated and lead several workshops and roundtable conferences with poor women workers from informal economy on the nexus of “Women\, Work and Energy”\, “Women\, work and Climate Action” as well as “Role of Informal sector Women Workers in the Food systems”. She has closely assisted Ms. Nanavaty in drafting the strategy for SEWA’s “Clear Skies Campaign” – a campaign to build resilience of SEWA members against the increasingly frequent climate shocks and to bring visibility to their climate action.  \nMansi has been leading SEWA’s work in the areas of Energy\, Climate Change and Renewable Energy and has represented SEWA at various international workshops\, conferences and policy dialogues such as the COP27\, Global Forum on Adaptive Social Protection\, One Planet 4th Global Conference on Sustainable Food Systems\, UNFSS+2 Stock-taking Moment in Rome etc. As a lead coordinator for SEWA’s “Future of Work” initiatives\, Mansi has orchestrated and lead several workshops and roundtable conferences with poor women workers from informal economy; especially with women from fragile and conflict affected areas like Sri Lanka\, Afghanistan\, Myanmar as well as Indian states like Kashmir and north-eastern states like Sikkim\, Nagaland and Meghalaya.  \n  \n \nKapilaben Vankar\, Member and Former President\, SEWA \nKapilaben Vankar is a grassroots leader and has been a member of SEWA for 22 years. She is the past president of SEWA\, who helped drive SEWA’s membership to over 2.5 million across 18 states in India. She is a also farmer from the Anand district of Gujarat. In her role as the president of SEWA\, Kapilaben represented SEWA’s members\, their challenges and their struggle for voice\, visibility and validity at various national and international forums and platforms including to the former US first lady Sec. Hillary Clinton. \n  \n  \n  \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/coffee-sessions-june-2024/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/06/6-28-24-HGHI-Coffee-Sessions-Promo-Image-900x600px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240618T120000
DTEND;TZID=America/Halifax:20240618T124500
DTSTAMP:20260413T085414
CREATED:20240605T145532Z
LAST-MODIFIED:20240617T204743Z
UID:10000233-1718712000-1718714700@globalhealth.harvard.edu
SUMMARY:Climate Change and Respiratory Health: From Epidemiology to Intervention
DESCRIPTION:  \n \nDr. Mary B. Rice will discuss research on the respiratory health effects of climate change and opportunities for physicians and scientists to intervene at the clinical and policy level. \nDr. Satchit Balsari will moderate the session\, with an introduction by Dr. Louise C. Ivers. \nThis event is free and open to the public. \nAbout the Speakers\n \nMary B. Rice\, MD\, MPH\, Director of the BIDMC Institute for Lung Health\, Associate Professor of Medicine at Harvard Medical School \nDr. Rice’s research focuses on preventable causes of chronic lung disease in children and adults\, including environmental exposures such as air pollution\, climate\, aeroallergens and microbes. Dr. Rice is the Director of the BIDMC Institute for Lung Health\, a multi-disciplinary respiratory research program that applies advanced statistical and sampling methodologies in clinical populations with chronic lung disease and multiple U.S.-based prospective cohort studies of children and adults. A core mission is to identify preventable causes of chronic lung disease\, and to translate research findings into patient care and health policies that improve lung health. Dr. Rice’s research is funded by the National Institutes of Health. \n  \n  \n \nSatchit Balsari\, MD\, MPH\, Associate Professor\, Emergency Medicine\, Harvard Medical School and Beth Israel Deaconess Medical Center; Department of Global Health and Population\, Harvard T.H. Chan School of Public Health \nDr. Satchit Balsari is Associate Professor in Emergency Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center; and in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health. Dr. Balsari’s research and teaching are focused on complex humanitarian emergencies and digital health implementation science in resource-poor settings. He has worked with populations affected by disaster\, war and the COVID-19 pandemic in Iraq\, South Sudan\, Jordan\, Haiti\, Puerto Rico and across South Asia. In the most vulnerable communities in the world\, his team has leveraged cutting-edge digital tools and citizen science to advance public health planning\, advocacy\, and response. \nThe Balsari Lab collaborates directly with populations in distress\, humanitarian response agencies\, civil society organizations\, governments\, and international agencies\, to reduce the information asymmetry that threatens to exclude the poor and disadvantaged from decisions that will impact their lives. Dr. Balsari co-directs CrisisReady.io\, a research-response platform that builds data-driven decision tools for local communities and response agencies affected by disasters globally. Dr. Balsari is founding director of the tri-institute Climate and Human Health fellowship at Harvard\, leads the climate platform at the Lakshmi Mittal and Family South Asia Institute\, and is co-investigator on the Salata Institute’s inaugural interfaculty cluster grant on Climate Change Adaptation in South Asia. He recently has curated an exhibition\, Hum Sab Ek\, which is based on his research on the impact of the COVID-19 pandemic on the 2.9 million-strong Self Employed Women’s Association (SEWA)\, and its members’ response to it. \nPrior signature initiatives include EMcounter (a customizable\, portable digital surveillance tool\, the latest iteration of which was used at the world’s largest mass gathering\, the Kumbh Mela in India) and Voices\, a crowd-sourced\, online disaster response analysis tool. In 2018\, in collaboration with Professor Caroline Buckee (Epidemiology)\, he co-led the Hurricane Maria Mortality Study. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-speaker-series-3-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/06/Mary-Rice-6-18-2024-900-x-600px-no-QR-code.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240612T000000
DTEND;TZID=UTC:20240612T133000
DTSTAMP:20260413T085414
CREATED:20240611T193043Z
LAST-MODIFIED:20240611T194441Z
UID:10000698-1718150400-1718199000@globalhealth.harvard.edu
SUMMARY:H5N1: The Current State of the Avian Flu Outbreak
DESCRIPTION:What is the current public health threat and what response is required to mitigate the H5N1 Avian Influenza Virus outbreak? During this event our speakers will bring expertise in veterinary health\, virology\, infectious disease\, One Health and epidemiology to break down the answers to those questions. In a conversation led by Dr. Louise Ivers\, experts will dive into the evolution of prior H5N1 outbreaks and explore why animal to human transmission of viruses poses a real threat to public health. \n  \nAbout our Speakers\n \nEllen Carlin\, DVM\, Founder of Parapet Science & Policy Consulting \nEllen P. Carlin\, DVM is the founder of the animal and public health firm Parapet Science & Policy Consulting and is also a vice president with Pathway Policy Group. She studies the epidemiology of emerging infections\, particularly risk factors for zoonotic spillover\, and supports development of improved policies to address them. She served for more than five years as staff on Capitol Hill with the U.S. House of Representatives Committee on Homeland Security. Her book\, Catastrophic Incentives: Why Our Approaches to Disasters Keep Falling Short\, was published with co-author Jeff Schlegelmilch in 2023. \n \nMartin S. Hirsch\, MD\, Professor of Medicine at Harvard Medical School; Physician at Massachusetts General Hospital \nMartin S. Hirsch is a Professor of Medicine at Harvard Medical School and Physician at the MGH. For over 50 years\, he has been involved in virology research and training. Since 1981\, the major focus of his laboratory and clinical research has been on HIV pathogenesis and therapy. His laboratory was the first to demonstrate that certain combinations of antiretroviral drugs were synergistic in vitro\, opening the door to clinical trials of combination therapy that have helped revolutionize the treatment of HIV infections. He also served as the Editor-in-Chief of the Journal of Infectious Diseases for 2 decades and is one of the Editors-in-Chief for infectious disease topics for UpToDate. Dr. Hirsch has trained many fellows who have become leaders in HIV research and Infectious Diseases and was the first recipient of the Infectious Disease Society of America (IDSA) Mentor Award. He has received additional honors\, including the Clinical Virology Award from the Pan American Society for Clinical Virology\, the Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases\, the Lifetime Achievement Award from the International Antiviral Society –USA (IAS-USA)\, and the Alexander Fleming Award for Lifetime Achievement from the IDSA. \n \nTim Uyeki\, MD\, MPH\, MPP\, Chief Medical Officer\, Influenza Division\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention (CDC) \nDr. Tim Uyeki is the chief medical officer in the Influenza Division\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention (CDC). He has worked at CDC on the clinical aspects\, epidemiology\, prevention\, and control of influenza in the United States and worldwide since 1998. Dr. Uyeki is an associate clinical professor of pediatrics at USCF\, an attending physician at Zuckerberg San Francisco General Hospital\, and adjunct professor in the Department of Global Health\, Public Health at Emory University. Dr. Uyeki has been a consultant to the World Health Organization (WHO) for many years on clinical and epidemiological issues related to seasonal\, zoonic\, and pandemic influenza\, SARS-Cov; MERS-CoV\, and Ebola virus diseases. \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \n  \nSpeakers will share their own perspectives; they do not speak for the university.
URL:https://globalhealth.harvard.edu/event/h5n1-the-current-state-of-the-avian-flu-outbreak/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/06/H5N1-Webinar-900x600px-no-QR-Code.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240531T090000
DTEND;TZID=UTC:20240531T094500
DTSTAMP:20260413T085414
CREATED:20240521T170348Z
LAST-MODIFIED:20240530T153641Z
UID:10000615-1717146000-1717148700@globalhealth.harvard.edu
SUMMARY:Leveraging Partnerships to Improve the Health of Young People Living with HIV in Peru
DESCRIPTION:This event will showcase the essential role of partnerships in designing and evaluating interventions for young people affected by HIV in Peru by spotlighting the successful partnership between Dr. Molly Franke\, Associate Professor of Global Health and Social Medicine at the Harvard Medical School\, and Dr. Renato Errea\, Head of the HIV Program at Socios En Salud. Our speakers will describe the tangible impact their work has had on improving access to HIV care for Peruvian adolescents and will offer valuable insights into how they have navigated complex challenges through a bidirectional partnership. \nAbout the HGHI Coffee Sessions\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on HGHI’s YouTube Channel. \nAbout our Speakers\nMolly Franke\, SD\, Associate Professor and Epidemiologist\, Global Health Research Core\, Department of Global Health and Social Medicine\, Harvard Medical School \n \nDr. Molly Franke is an epidemiologist and Associate Professor in Global Health and Social Medicine at Harvard Medical School. For nearly 20 years she has collaborated with Socios En Salud on research to improve the health of children and adolescents affected by TB and HIV. Her current intervention work includes studies to reduce stigma and improve the well-being of adolescents and young adults living with HIV through the provision of community-based accompaniment and youth-friendly modalities\, such as music videos and social media. \nRenato Errea\, MD\, MMSc\, Head\, HIV Program\, Socios En Salud \n \nDr. Renato Errea is a Peruvian physician researcher with nearly a decade of experience conducting global health research and interventions focused on people affected by HIV and other vulnerable populations in Peru. Dr. Errea is the Head of the HIV Program at the Peruvian non-governmental organization Socios En Salud. In this role\, he leads interventions and studies focused on facilitating access to comprehensive care to the communities most affected by HIV and other prioritized populations in the context of HIV (adolescents and migrants)\, in Peru.
URL:https://globalhealth.harvard.edu/event/leveraging-partnerships/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/Leveraging-Partnerships-Coffee-Session-Image-for-Event-listing.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240514T120000
DTEND;TZID=UTC:20240514T124500
DTSTAMP:20260413T085414
CREATED:20240506T132924Z
LAST-MODIFIED:20240506T152429Z
UID:10000227-1715688000-1715690700@globalhealth.harvard.edu
SUMMARY:Innovation in the Treatment of Drug-resistant Tuberculosis: The endTB Clinical Trial
DESCRIPTION:LEARN MORE/REGISTER \nIn this Global Health Research and Innovations Speaker Series event\, Dr. Carole Diane Mitnick\, ScD\, Professor of Global Health and Social Medicine at Harvard Medical School will share her work on the endTB clinical trial. Dr. Louise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director at the Harvard Global Health Institute\, will moderate the conversation. \nPLEASE CLICK HERE TO REGISTER \nEvent Description\nFor decades\, poor treatment options and low-quality evidence plagued care for rifampin-resistant tuberculosis (RR-TB). The advent of new anti-TB drugs and enhanced funding now permit randomized controlled trials of shortened\, all-oral treatment for resistant TB. \nMethods \nendTB is an international\, open-label\, Phase 3 non-inferiority\, randomized\, controlled clinical trial to compare five 9-month all-oral regimens including bedaquiline (B)\, delamanid (D)\, linezolid (L)\, levofloxacin (Lfx) or moxifloxacin (M)\, clofazimine (C) and pyrazinamide (Z)\, to the standard (control) for treatment of fluoroquinolone-susceptible RR-TB. Participants were randomized to 9BLMZ\, 9BCLLfxZ\, 9BDLLfxZ\, 9DCLLfxZ\, 9DCMZ and control using Bayesian response-adaptive randomization. The primary outcome was favorable outcome at week 73 defined by two negative sputum culture results or by favorable bacteriologic\, clinical\, and radiologic evolution. The non-inferiority margin was 12 percentage points. \nResults \nOf 754 randomized patients\, 696 and 559 were included in the modified intention to treat (mITT) and per-protocol (PP) analyses\, respectively. In mITT\, the control had 80.7% favorable outcomes. Regimens 9BCLLfxZ [adjusted risk difference (aRD): 9.5% (95% confidence interval (CI)\, 0.4 to 18.6)]\, 9BLMZ [aRD: 8.8% (95%CI\, -0.6 to 18.2)]\, and 9BDLLfxZ [3.9% (95%CI\, -5.8 to 13.6)] were non-inferior in mITT and in PP. The proportion of participants experiencing grade 3 or higher adverse events was similar across the regimens. Grade 3 or higher hepatotoxicity occurred in 11.7% of the experimental regimens overall and in 7.1% of the control. \nConclusions \nThe endTB trial increases treatment options for RR-TB with three shortened\, all-oral regimens that were non-inferior to a current well-performing standard of care. \nPLEASE CLICK HERE TO REGISTER \nAbout the Speakers\nCarole Diane Mitnick\, ScD\, Professor of Global Health and Social Medicine\, Harvard Medical School \nDr. Mitnick is Professor of Global Health & Social Medicine at Harvard Medical School (HMS) and Associate Epidemiologist in the Division of Global Health Equity at Brigham & Women’s Hospital. She has 25 years of experience in programmatic support\, research (observational and experimental)\, policy\, and advocacy related to increased access to high-quality\, appropriate treatment for TB\, especially for drug-resistant TB. Dr. Mitnick works in close collaboration with Partners In Health\, specifically in Peru\, Haiti\, Kazakhstan\, and Lesotho. In addition to teaching at HMS and giving lectures at other institutions\, Dr. Mitnick mentors trainees in the HMS Master of Medical Science in Global Health Delivery Program. She is the co-PI of the endTB and endTB-Q trials\, two multi-country\, Phase III\, randomized\, controlled\, clinical trials of all-oral\, shortened\, novel regimens for rifampin-resistant TB. She has also recently begun conducting research on post-TB lung disease. \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute; Executive Director\, Massachusetts General Hospital Center for Global Health \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \nAbout the Global Health Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for the university.
URL:https://globalhealth.harvard.edu/event/innovation-in-the-treatment-of-drug-resistant-tuberculosis-the-endtb-clinical-trial/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240426T090000
DTEND;TZID=America/Halifax:20240426T094500
DTSTAMP:20260413T085414
CREATED:20240403T131429Z
LAST-MODIFIED:20240614T171419Z
UID:10000223-1714122000-1714124700@globalhealth.harvard.edu
SUMMARY:Better Evidence\, Better Training\, Better Care: Supporting current and future clinicians in Africa to use evidence-based digital tools
DESCRIPTION:This session will explore the partnerships and people that enable Better Evidence at Ariadne Labs to support the frontline health workforce to make the best decisions when and where it matters most. Through 108 local Champions\, the Better Evidence for Training program is facilitating access to digital tools for nearly 90\,000 students and faculty at more than 59 medical schools across 16 countries in sub-Saharan Africa. This session will feature Biliamin Popoola\, President of the Better Evidence for Training Champion Steering Committee and Librarian at the University of Medical Sciences in Nigeria\, and Julie Rosenberg \, Associate Director of Better Evidence. The two will discuss the importance and lessons of partnerships\, how digital tools impact the global health landscape\, and how the program aims to impact global health equity in both the short- and the long run. \nAbout the HGHI Coffee Sessions\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on HGHI’s YouTube Channel.  \nAbout our Speakers\nJulie Rosenberg\, MPH\, Associate Director\, Better Evidence\, Ariadne Labs  \n \nJulie Rosenberg\, MPH\, is Associate Director\, Better Evidence at Ariadne Labs\, a program working to help current and future health care providers access the latest clinical knowledge at the front lines of care delivery through digital tools. With the Director\, she has led the scale-up strategy\, research and program operations\, leveraging in-kind donations and funding to maximize the impact of the program on patient outcomes.  \nJulie is also Deputy Director of the Global Health Delivery Project at Harvard where she supports health care providers by studying what works in health care delivery and sharing those lessons through courseware and training. Julie has helped lead the development of over 45+ open-access teaching cases published through Harvard Business Publishing and supported the development of an online community of practice engaging 25\,000+ global health providers for over a decade.  \nPreviously\, Julie worked in clinical research at Emory University School of Medicine and in community-based nonprofit organizations in Latin America and the US. Julie is currently pursuing her DrPh in public health leadership. She has an MPH in epidemiology and global health from the Rollins School of Public Health at Emory University and a BA in anthropology\, with pre-med coursework and a Spanish language certificate\, from Harvard College. \nBiliamin Oladele Popoola\, MLIS\, Systems\, Scholarly Communications\, and Evidence-Based Medicine Librarian\, Champion for the Better Evidence for Training Program\, University of Medical Sciences\, Ondo City\, Nigeria  \n \nBiliamin Oladele Popoola is an academic librarian\, researcher\, and knowledge management professional from Nigeria. He holds a Bachelor’s Degree in Human Anatomy\, a Master’s Degree in Library and Information Studies (MLIS)\, and is currently a PhD candidate at the University of Ilorin\, Nigeria. He works as the Systems\, Scholarly Communications\, and Evidence-Based Medicine Librarian at the University of Medical Sciences\, Ondo City\, Nigeria\, where he also serves as a Champion for the Better Evidence for Training programme at the institution. \nBiliamin is a Fellow of the Carnegie Next-Generation Librarians Fellowship Programme at the University of Pretoria\, South Africa\, and a recipient of the Cunningham International Fellowship by the Medical Library Association\, U.S.A. He is also on the NIH’s DS-I Africa Consortium’s Data Science Librarians team and presently leads the Champions Steering Committee for the Better Evidence for Training programme at Ariadne Lab.  \nBiliamin has published widely and presented papers at conferences. He has served as a facilitator\, trainer\, and panellist on several occasions. He is a reviewer and editor for some scholarly journals in librarianship and currently serves as the Secretary-General for the Association for Health Information and Libraries in Africa (AHILA).  \nBiliamin has a special interest in health information librarianship\, public health\, knowledge management\, professional development\, knowledge synthesis\, information literacy\, and emerging technologies. 
URL:https://globalhealth.harvard.edu/event/better-evidence-better-training-better-care-supporting-current-and-future-clinicians-in-africa-to-use-evidence-based-digital-tools/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/04/Julie-Rosenberg-Coffee-Sessions-Zoom-Banner-Image-1080-x-400-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240418
DTEND;VALUE=DATE:20240419
DTSTAMP:20260413T085414
CREATED:20230921T104254Z
LAST-MODIFIED:20240528T191907Z
UID:10000216-1713398400-1713484799@globalhealth.harvard.edu
SUMMARY:2024 Global Health Symposium
DESCRIPTION:The Harvard Global Health Institute’s annual Global Health Symposium provides the opportunity for faculty\, staff\, and students across Harvard’s schools\, institutes\, centers\, departments\, and affiliated hospitals\, as well as an international community of health professionals\, academics\, and civil society\, to connect and engage in meaningful conversations around some of the most pressing global health issues in an inclusive hybrid experience. \nRead more on our 2024 Global Health Symposium webpage.
URL:https://globalhealth.harvard.edu/event/2024-global-health-symposium/
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/10/2024-Global-Health-Symposium-Partnerships-in-Action-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240411T120000
DTEND;TZID=America/Halifax:20240411T130000
DTSTAMP:20260413T085414
CREATED:20240401T093712Z
LAST-MODIFIED:20240614T171550Z
UID:10000220-1712836800-1712840400@globalhealth.harvard.edu
SUMMARY:Pathways to Global Health: Climate Change and Health
DESCRIPTION:Join us for this informal in-person session for Harvard undergraduates to connect with our current 2023 HGHI Burke Climate and Health Fellows\, Annikki Herranen-Tabibi\, PhD\, and Jenny Lee\, PhD. Learn about their career journeys in the intersection of climate change and health — over pizzas and soft drinks! \nAnnikki Herranen-Tabibi (she/her) is a medical and environmental anthropologist of the Circumpolar Arctic. She is engaged in long-term ethnographic research in Sápmi\, the transborder homeland of the Indigenous Sámi people. Her scholarly work defines a space for research and collaborative action at the intersections of global health with medical and environmental humanities and social sciences. Across these arenas\, her work is grounded in questions of care – interpersonal\, intergenerational\, and ecological. \nJenny Lee is a Postdoctoral Fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health . She received an M.S. in Biostatistics from Yale University and received her Ph.D. in Biostatistics from Harvard University. Her work has focused on assessing the health impacts of air pollution on vulnerable populations\, including pregnant women\, children\, and the elderly\, with an aim to find policy implications that provide actionable insights for policymakers. Her research focuses on developing statistical methods for assessing the impact of exposure to multi-pollutant mixtures during pregnancy on high-dimensional epigenetic markers in newborns\, and developing causal inference methods for clustered data in environmental health to assess effects of air pollution on socioeconomically disadvantaged children and elderly in the U.S.
URL:https://globalhealth.harvard.edu/event/pathways-to-global-health-climate-change-and-health/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240409T120000
DTEND;TZID=America/Halifax:20240409T124500
DTSTAMP:20260413T085414
CREATED:20240312T124949Z
LAST-MODIFIED:20240517T195704Z
UID:10000219-1712664000-1712666700@globalhealth.harvard.edu
SUMMARY:Global Health Research and Innovation Speaker Series with Milind Tambe
DESCRIPTION:For over 15 years\, Dr. Tambe and his team have been focused on AI for social impact\, deploying end-to-end systems in areas of public health\, conservation\, and public safety. In this talk\, he will highlight the results from their deployments for social impact in public health\, as well as required innovations in integrating machine learning and optimization. Dr. Tambe will present recent results from their work in India with the world’s two largest mobile health programs for maternal and childcare that have served millions of beneficiaries\, and on-going projects focused on other mobile health programs. Additionally\, he will highlight results from an earlier project on HIV prevention among youth experiencing homelessness in Los Angeles. To address challenges of ML+optimization common to all of these applications\, Dr. Tambe and his team have advanced the state of the art in decision-focused learning\, restless multi-armed bandits and influence maximization in social networks. \nPLEASE CLICK HERE TO REGISTER \n  \nAbout Milind Tambe\, PhD\, MSc \nDr. Milind Tambe is Gordon McKay Professor of Computer Science and Director of Center for Research on Computation and Society at Harvard University; concurrently\, he is also Principal Scientist and Director for “AI for Social Good” at Google Research. Dr. Tambe is a recipient of the AAAI Award for Artificial Intelligence for the Benefit of Humanity\, AAAI Feigenbaum Prize\, IJCAI John McCarthy Award\, AAAI Robert S. Engelmore Memorial Lecture Award\, AAMAS ACM Autonomous Agents Research Award\, INFORMS Wagner prize for excellence in Operations Research practice\, Military Operations Research Society Rist Prize\, and the Columbus Fellowship Foundation Homeland security award. Dr. Tambe is a fellow of AAAI and ACM. Dr. Tambe’s work focuses on advancing AI and multiagent systems for public health\, conservation\, and public safety\, with a track record of building pioneering AI systems for social impact. \nYou can read more about Dr. Milind Tambe on his website\, X\, LinkedIn\, and Facebook. \n  \nAbout the Global Health Research and Innovation Speaker Series \nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard. \nPLEASE CLICK HERE TO REGISTER
URL:https://globalhealth.harvard.edu/event/global-health-research-and-innovation-speaker-series-with-milind-tambe/
LOCATION:Zoom\, Virtual: Zoom
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/03/Research-and-Innovations-Promo-Image-Landscape-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240404T130000
DTEND;TZID=America/Halifax:20240404T140000
DTSTAMP:20260413T085414
CREATED:20240401T125504Z
LAST-MODIFIED:20240614T171550Z
UID:10000222-1712235600-1712239200@globalhealth.harvard.edu
SUMMARY:Empowering Healthier Communities: How Health Promotion Research Can Advance the Philippines’ Universal Health Care Journey
DESCRIPTION:Featuring Katherine Ann V. Reyes\, MD\, MPP\, LEAD fellow at the Harvard Global Health Institute and Harvard T.H. Chan School of Public Health \nThursday\, April 4th\, 1:00 – 2:00 PM ET\n(Hybrid) 665 Huntington Avenue\, Building 1\, Room 1208\, Boston\, MA 02115 and via Zoom \nTo attend a hybrid seminar in-person\, a Harvard ID is required to access the building.\nFor questions\, please contact Jessica Majano jmajanoguevara@hsph.harvard.edu. \n\n\nDr. Katherine Ann Reyes is a licensed Philippine physician and holds a Master of Public Policy from the National University of Singapore. She was recently appointed Program Lead to establish the Institute of Health Promotion at the National Institutes of Health University of the Philippines Manila\, a key component in the implementation of the country’s UHC Law. She co-founded the Alliance for Improving Health Outcomes (AIHO)\, a local non-profit public health organization that has worked to improve opportunities for aspiring professionals in their field. She served as an inaugural member of the Philippine Health Technology Assessment Council and the UP Manila Committee of Research Integrity. She was also the first Board Member for the Western Pacific Region at Health Systems Global\, where she helped to formalize the society’s expansion work in the region. Further\, Dr. Reyes is a founding member of the Philippine Society of Public Health Physicians and a co-convener of Women in Global Health Philippines. In recognition of her work\, Dr. Reyes was awarded the Gawad Lagablab for Social Upliftment by the Philippine Science High School National Alumni Association in 2021. \n  \n\nSpeakers’ remarks are based on their own scholarship and experience. As such\, they speak for themselves\, not for Harvard.
URL:https://globalhealth.harvard.edu/event/empowering-healthier-communities-how-health-promotion-research-can-advance-the-philippines-universal-health-care-journey/
LOCATION:Hybrid (In-person and online)\, MA\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/04/Empowering-Healthier-Communities-Event-Flyer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240229T120000
DTEND;TZID=America/Halifax:20240229T130000
DTSTAMP:20260413T085414
CREATED:20240222T165816Z
LAST-MODIFIED:20240419T154802Z
UID:10000139-1709208000-1709211600@globalhealth.harvard.edu
SUMMARY:Pathways to Global Health with Shela Sridhar\, MD\, MPH
DESCRIPTION:Join us for this informal in-person session for Harvard undergraduates to connect with our current 2023 HGHI Burke Global Health Fellow\, Shela Sridhar\, MD\, MPH. Learn about her career journey in global health over pizzas and soft drinks! \nShela Sridhar is a 2023 HGHI Burke Global Health Fellow. She is an internal medicine and pediatrics-trained physician working as a hospitalist at Brigham and Women’s Hospital and Boston Children’s Hospital (BCH). She completed a Global Health Service Delivery Fellowship at BCH where she worked on health system strengthening initiatives.
URL:https://globalhealth.harvard.edu/event/pathways-to-global-health-with-shela-sridhar-md-mph/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/02/Banner-Shela-Sridhar-Pathway-to-Global-Health-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240228T173000
DTEND;TZID=America/Halifax:20240228T183000
DTSTAMP:20260413T085414
CREATED:20240226T180646Z
LAST-MODIFIED:20240419T154802Z
UID:10000140-1709141400-1709145000@globalhealth.harvard.edu
SUMMARY:Educating Future Global Health Practitioners in One of the Most Remote Places in the World
DESCRIPTION:In-person event. Available to Harvard Undergraduate Students only. In-person capacity is limited and available on a first come first serve basis. \nThe Harvard Global Health Institute  is pleased to welcome Dr. Mangal Rawal\, Vice Chancellor of Karnali Academy of Health Sciences (KAHS)\, a medical university in one of the most remote areas of the world\, to Harvard’s campus on Wednesday\, February 28th. In this interactive event\, Dr. Rawal will discuss rural health equity and share the mission\, achievements\, operations\, and challenges of running a medical university in a remote region. The conversation will be moderated by Pradish Poudel\, MD\, graduate student in Global Health Delivery at Harvard Medical School. Students will get insider knowledge about health equity in rural areas such as Karnali\, Nepal\, and gain insight on the challenges and inner workings of health organizations like KAHS. \nKarnali Academy of Health Sciences (KAHS) is a medical university established by the government of Nepal to enable access to quality healthcare services and education at an affordable cost for the people of under resourced areas in Jumla. Dr Rawal\, the Vice Chancellor of KAHS\, has played a pivotal role in establishing and advancing the organization\, setting an example for how to successfully operate a medical university in one of the most remote areas of the world. \nMangal Rawal\, MD\, MPA was born in a remote village of the Karnali Province in Nepal. He defied the odds to pursue education\, completing traditional schooling in his village before advancing for further studies. Despite limited resources\, he obtained his MBBS/MD from BPKIHS and Residency in Orthopedics from NAMS\, Kathmandu\, both on government scholarships. Following this\, he pursued an AOA Fellowship in Trauma in Dhaka\, Bangladesh\, and earned a master’s in public administration (MPA) from Tribhuvan University. Recognized for his dedication to rural health\, he was appointed as the Vice Chancellor of Karnali Academy of Health Sciences (KAHS) by then Prime Minister of Nepal\, becoming the youngest Vice Chancellor in Nepalese history. His tenure witnessed groundbreaking initiatives\, including establishing undergraduate and postgraduate medical education programs in a remote medical school. During the COVID-19 pandemic\, his leadership as the hospital director of KAHS earned him the prestigious President’s Medal for extraordinary contributions. Driven by a vision to transform KAHS into a center of excellence for rural health\, medicinal herbs research\, and mountain medicine\, Dr. Rawal remains committed to serving the communities of Karnali with clinical expertise and social advocacy.
URL:https://globalhealth.harvard.edu/event/educating-future-global-health-practitioners-in-one-of-the-most-remote-places-in-the-world/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/02/Mangal-Rawal-Event-Promo-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240222T120000
DTEND;TZID=America/New_York:20240222T130000
DTSTAMP:20260413T085414
CREATED:20240207T164546Z
LAST-MODIFIED:20240514T182408Z
UID:10000138-1708603200-1708606800@globalhealth.harvard.edu
SUMMARY:Power and Money in Global Health: A conversation with Tim Schwab about "The Bill Gates Problem: Reckoning with the Myth of the Good Billionaire"
DESCRIPTION:In this interactive\, hybrid event\, Alicia Ely Yamin\, JD\, MPH\, PhD\, will moderate a conversation with investigative journalist and author Tim Schwab about his latest book\, The Bill Gates Problem: Reckoning with the Myth of the Good Billionaire. Audiences\, both in-person and online\, will have the opportunity to join in the discussion. This event is part of HGHI’s Scholarly Working Group Initiative. It is being co-hosted by the Harvard Global Health Institute (HGHI) and the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School\, and in partnership with the François-Xavier Bagnoud (FXB) Center for Health and Human Rights and the Program on Law and Political Economy at Harvard Law School. \n\n  \n To join the event virtually\, please click here to register \n  \nIn earlier eras\, the super-wealthy—Carnegie\, Rockefeller\, Frick and the like—were denominated as “robber barons”. They were pilloried by the popular news media and investigated in some situations. But that is not the case with Bill Gates\, who has been lauded for his philanthropy in global health. Based on investigative journalist\, Tim Schwab’s\, exhaustively researched new book\, this event will take a closer look at Bill Gates’ approach to global health\, and what has come to be called “philanthrocapitalism.” \nThe rise of philanthrocapitalism is tied to a shift in thinking about development and the role of the state in global health governance. Bill Gates and the Gates Foundation are worthy of particular focus because their investments dwarf those of other private foundations. The Gates Foundation’s investments in global health rival those of top donor countries; Gates himself played an outsized role in influencing the selection of the COVAX facility for COVID-19 vaccines as opposed to the COVID-19-Technology Access Pool (C-TAP) housed under the World Health Organization. The Gates Foundation\, on the one hand\, sets agendas for global health\, and on the other is not subject to accountability for the actions implemented\, the means and metrics used\, nor the priorities set. \nMany academic researchers at top teaching and research institutions\, including Harvard University\, rely on Gates money for their research priorities; Gates funding and the paradigm of metrics they espouse have also had deep impacts on the curricula in global public health\, and in turn on the sorts of candidates sought and the skills they will have upon graduation. As governments increasingly are unable or unwilling to invest in health as a global public good\, private philanthropies such as Gates can create institutions\, set agendas\, and shape development in ways that were inconceivable only a matter of decades ago. \n\n  \nAbout Tim Schwab\nTim Schwab is an investigative journalist based in Washington\, DC. His groundbreaking reporting on the Gates Foundation for The Nation\, Columbia Journalism Review\, and The British Medical Journal has been honored with an Izzy Award and a Deadline Club Award. The Bill Gates Problem is his first book. \nThe New York Times recently highlighted his forthcoming book (Henry Holt Books)\, The Bill Gates Problem\, as one to look out for in November; Booklist (American Library Association) gave it a starred review; and Kirkus called it an “An eye-opening look at the use of tax-subsidized money by private philanthropy.” \nThe book builds on an investigative series I published in 2020 and 2021\, which was funded through an Alicia Patterson reporting fellowship. This series won an Izzy Prize (from Ithaca College) and a Deadline Club Award (from the Society of Professional Journalists)\, and was a finalist for a Mirror Award (from Syracuse University). The Nation nominated his series on Gates for a Pulitzer. \nHis reporting on Gates has appeared in The Nation\, Columbia Journalism Review\, and the British Medical Journal\, and represents some of the only investigative journalism ever published on Gates. \nYou can read more about Tim Schwab on his website. \n  \n\n  \nAbout Alicia Ely Yamin\, JD\, MPH\, PhD\nAlicia Ely Yamin\, JD\, MPH\, PhD\, is a Lecturer on Law and the Senior Fellow on Global Health and Rights at the Petrie-Flom Center for Health Law Policy\, Biotechnology and Bioethics at Harvard Law School; Adjunct Senior Lecturer on Health Policy and Management at the Harvard TH Chan School of Public Health; and Senior Advisor on Human Rights and Health Policy at the global health justice organization\, Partners In Health. \nKnown globally for her trans-disciplinary work in relation to economic and social rights\, sexual and reproductive health and rights\, the right to health\, and the intersections between development paradigms and human rights\, Yamin’s career has bridged academia and activism. She has lived in Latin America and East Africa for much of her professional life and worked with local advocacy organizations\, including co-founding a program on health and human rights in the Asociación Pro Derechos Humanos (Lima\, Peru; 1999). \nYamin was appointed by the UN Secretary General as one of ten international experts to the Independent Accountability Panel for Women’s\, Children’s and Adolescents’ Health in the Sustainable Development Goals (2016-2021). She was the chief consultant to the Office of the High Commissioner for Human Rights and drafter of the ‘Technical guidance on the application of a human-rights based approach to the implementation of policies and programmes to reduce preventable maternal morbidity and mortality’\, the first guidance on a ‘human rights-based approach to health’ to be adopted by the UN Human Rights Council. \nYamin holds Juris Doctor and Master’s in Public Health degrees from Harvard University\, and a Doctorate in Law from the University of Buenos Aires in Argentina. She has published multiple books and over 160 articles in law and policy journals\, as well as peer-reviewed public health journals\, in both English and Spanish. A revised and substantially expanded edition of her latest monograph\, When Misfortune becomes Injustice: Evolving Human Rights Struggles for Health and Social Equality\, is out from Stanford University Press in 2023. \nYou can read more about Alicia Ely Yamin on her faculty page. \n  \n\n  \nAbout the Harvard Global Health Institute\nThe Harvard Global Health Institute is an interfaculty initiative that facilitates collaboration across the Harvard community and partners worldwide to advance global health equity. We tackle the greatest health challenges of our time through innovative transdisciplinary research\, education\, and partnerships that build knowledge and drive positive change in global health. Our work is grounded in the fact that researchers\, scholars\, care deliverers\, and communities must inform each others’ work to transform global health at every level. \n  \nAbout the Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics\nThe Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics at Harvard Law School was founded in 2005 through a generous gift from Joseph H. Flom and the Carroll and Milton Petrie Foundation. The Center’s founding mission was to promote interdisciplinary analysis and legal scholarship in these fields. Today\, the Center has grown into a leading research program dedicated to the unbiased legal and ethical analysis of pressing questions facing health policymakers\, medical professionals\, patients\, families\, and others who influence and are influenced by health care and the health care system. \n  \nAbout the HGHI Scholarly Working Group\nThe Harvard Global Health Institute’s Scholarly Working Groups are designed to encourage a collaborative environment\, promote inter-faculty gatherings\, and explore and accelerate research areas in topics critical to the advancement of “Health for All”. Each Scholarly Working Group includes faculty from at least two schools across Harvard University. Through these working groups\, we aim to catalyze ideas\, inspire the writing of grants\, policy briefs\, or working papers\, or build networks to advance a program of work. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience\, and do not imply endorsement by the Harvard Global Health Institute.
URL:https://globalhealth.harvard.edu/event/power-and-money-in-global-health-a-conversation-with-tim-schwab-about-the-bill-gates-problem-reckoning-with-the-myth-of-the-good-billionaire/
LOCATION:Hybrid (In-person and online)\, MA\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/02/Tim-promo-image-with-no-bitly.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231130T130000
DTEND;TZID=America/Halifax:20231130T140000
DTSTAMP:20260413T085414
CREATED:20230921T104010Z
LAST-MODIFIED:20240419T154801Z
UID:10000137-1701349200-1701352800@globalhealth.harvard.edu
SUMMARY:GHP Thursday Brown Bag Series with Marie Roseline Belizaire
DESCRIPTION:This event will feature Marie Roseline Belizaire\, 2023 LEAD fellow at the Harvard Global Health Institute. \nTopic: What we know and don’t know on how to effectively engage the community in health security \nHosted by the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health\, the Thursday Brown Bag Series features current research of members and affiliates of GHP.  The intent is to educate and raise the awareness of our community and beyond\, about the research activities presently being conducted by faculty\, students\, researchers\, and special guests of the department.
URL:https://globalhealth.harvard.edu/event/ghp-thursday-brown-bag-series-with-marie-roseline-belizaire/
LOCATION:Zoom\, Virtual: Zoom
ATTACH;FMTTYPE=image/webp:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/11.30.23-BB-flyer-v2.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231116T130000
DTEND;TZID=America/Halifax:20231116T140000
DTSTAMP:20260413T085414
CREATED:20230921T103620Z
LAST-MODIFIED:20240419T154801Z
UID:10000136-1700139600-1700143200@globalhealth.harvard.edu
SUMMARY:GHP Thursday Brown Bag Series with Brenda Kateera
DESCRIPTION:This event will feature Brenda Kateera\, 2023 LEAD fellow at the Harvard Global Health Institute. \nTopic: From Healing Hills to Healthcare for All: Rwanda’s Inspiring Path to Universal Coverage \nHosted by the Department of Global Health and Population (GHP) at the Harvard T.H. Chan School of Public Health\, the Thursday Brown Bag Series features current research of members and affiliates of GHP.  The intent is to educate and raise the awareness of our community and beyond\, about the research activities presently being conducted by faculty\, students\, researchers\, and special guests of the department.
URL:https://globalhealth.harvard.edu/event/ghp-thursday-brown-bag-series-with-brenda-kateera/
LOCATION:Zoom\, Virtual: Zoom
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/BrownBag-Series-ft.-Brenda-Kateera-flyer-11.16.23.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231115T120000
DTEND;TZID=America/Halifax:20231115T130000
DTSTAMP:20260413T085414
CREATED:20230921T103029Z
LAST-MODIFIED:20240419T154800Z
UID:10000135-1700049600-1700053200@globalhealth.harvard.edu
SUMMARY:Pathways to Global Health with Lao-Tzu Allan-Blitz
DESCRIPTION:Pathways to Global Health is an informal monthly series for Harvard undergraduate students to connect with global health experts and learn about their career journey. \nWe are excited to have Lao-Tzu Allan-Blitz\, 2023 Burke Global Health Fellow\, as our speaker. \nTopic: Health tech in resource-deprived settings\, ultrasound diagnostics\, community-based intervention design \nDr. Lao-Tzu Allan-Blitz is an instructor of medicine at Harvard Medical School\, and an internal medicine physician in the Division of Global Health Equity at Brigham and Women’s Hospital. He is also a fellow in point-of-care ultrasonography through the Brigham and Women’s Hospital Department of Emergency Medicine. Dr. Allan-Blitz earned his undergraduate degree in interdisciplinary studies with a colloquium in Happiness from New York University\, his medical degree from the David Geffen School of Medicine at UCLA\, and completed a combined internal medicine and pediatrics residency at Brigham and Women’s Hospital and Boston Children’s Hospital. He was also the chief resident of the Doris and Howard Hiatt Residency in Global Health Equity. He subsequently obtained his master’s in public health from the Harvard T.H. Chan School of Public Health. Dr. Allan-Blitz’s research focuses on bridging the diagnostic equity gap in resource-limited settings\, either through implementing existing technology such as point-of-care ultrasound\, designing and leading educational curricula\, or developing novel low-cost molecular diagnostic assays. His work has been conducted across Peru\, South Africa\, Botswana\, Malawi\, Mexico\, Sierra Leone\, Liberia\, Rwanda\, Lesotho\, Madagascar\, and rural Australia. \n*This event is for Harvard undergraduate students only. Lunch will be served.
URL:https://globalhealth.harvard.edu/event/pathways-to-global-health-w-lao-tzu-allan-blitz/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/Lao-Tzu-Pathways-Series-Flyer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231018T120000
DTEND;TZID=America/Halifax:20231018T130000
DTSTAMP:20260413T085414
CREATED:20231004T115845Z
LAST-MODIFIED:20240419T154801Z
UID:10000217-1697630400-1697634000@globalhealth.harvard.edu
SUMMARY:Pathways to Global Health with Maria Nardell
DESCRIPTION:Pathways to Global Health is an informal monthly series for Harvard undergraduate students to connect with global health experts and learn about their career journey. \nWe are excited to have Maria Nardell\, MD\, MPH\, 2023 Burke Global Health Fellow\, as our speaker. \nTopic: Migration\, HIV healthcare\, intervention design\, & community engagement \nMaria Nardell\, MD\, MPH is a researcher in the Division of Global Health Equity at Brigham and Women’s Hospital and a hospitalist physician at Beth Israel Deaconess Medical Center. She is interested in improving healthcare engagement for migrants and other vulnerable populations globally and locally. Her current projects focus on HIV care and prevention for migrants in South Africa\, and she has also worked in Rwanda\, Kenya\, Namibia\, and India. Her research has been supported by the Connors Center Global Women’s Health Fellowship (BWH)\, NIAID T32 Training Fellowship (MGH)\, a Harvard University Center for AIDS Research Developmental Award\, and a Hearst Young Investigator’s Award (BWH). As a Burke Global Health Fellow\, she will explore preferences for HIV prevention services among migrant men in South Africa in order to design a pre-exposure prophylaxis (PrEP) program for them. In addition to her research interests\, she enjoys supporting the professional development and wellbeing of students\, trainees and faculty through mentoring\, coaching\, and storytelling initiatives. \n*This event is for Harvard undergraduate students only. Registration is required. Lunch will be served.
URL:https://globalhealth.harvard.edu/event/pathways-to-global-health-with-maria-nardell/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalhealth.harvard.edu/wp-content/uploads/2023/10/11.15.23_Maria-Nardell_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231012T170000
DTEND;TZID=America/Halifax:20231012T180000
DTSTAMP:20260413T085414
CREATED:20231004T120204Z
LAST-MODIFIED:20240419T154801Z
UID:10000218-1697130000-1697133600@globalhealth.harvard.edu
SUMMARY:HGHI Summer Research & Internship Showcase
DESCRIPTION:Join us for a Global Health Internship Showcase\, where students from the Harvard Global Health Institute Summer Programs will present about their transformative summer research and internship experiences in Mexico\, Peru\, South Africa\, Rwanda\, England\, and more! \n 
URL:https://globalhealth.harvard.edu/event/hghi-summer-research-internship-showcase/
LOCATION:Zoom\, Virtual: Zoom
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/10/HGHI-Summer-Research-Internship-Showcase.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231010T163000
DTEND;TZID=America/Halifax:20231010T203000
DTSTAMP:20260413T085414
CREATED:20230921T102716Z
LAST-MODIFIED:20240419T154800Z
UID:10000215-1696955400-1696969800@globalhealth.harvard.edu
SUMMARY:World Mental Health Day Event
DESCRIPTION:Engage in profound conversations around the WHO theme\, “Mental Health is a Universal Human Right.” Our event features two remarkable authors: Jeremy Nobel\, author of ‘Project Unlonely\,’ discussing ‘Healing Our Crisis of Disconnection\,’ and Michele Lamont\, author of ‘Seeing Others\,’ shedding light on ‘How Recognition Works and How it Can Help Heal a Divided World.’ \nFollowing these thought-provoking talks\, immerse yourself in ‘The Listener\,’ a compelling film that addresses the pressing issues of brokenness and loneliness\, introduced by the director himself\, Steve Buscemi. Afterward\, don’t miss our insightful panel discussion moderated by Barbara Van Dahlen\, the CEO of WeBe Life foundation\, with Dr. Vikram Patel\, Chair of the Department of Global Health and Social Medicine at Harvard Medical School and Steve Buscemi. \n 
URL:https://globalhealth.harvard.edu/event/world-mental-health-day-event/
LOCATION:Sanders Theater\, 45 Quincy Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/World-Mental-Health-Day-Event-750-×-371-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230920T173000
DTEND;TZID=America/Halifax:20230920T183000
DTSTAMP:20260413T085414
CREATED:20230908T111548Z
LAST-MODIFIED:20240614T171550Z
UID:10000214-1695231000-1695234600@globalhealth.harvard.edu
SUMMARY:Pathways to Global Health with Demetrice "Dee" Jordan
DESCRIPTION:Pathways to Global Health is an informal monthly series for Harvard undergraduate students to connect with global health experts and learn about their career journey. \nWe are excited to have Demetrice “Dee” Jordan\, PhD\, MPH to kick off our Fall 2023. \nTopics: Climate change\, vector-borne diseases\, and health equity \nDee Jordan is an Instructor in the Department of Global Health and Social Medicine at Harvard Medical School and a 2023 HGHI Burke Fellow. Dee holds a dual-PhD in Health Geography and Environmental Science and Policy from Michigan State University\, as well as an MPH in Global Health from the Harvard T.H. Chan School of Public Health. \n*This event is for Harvard undergraduate students only. Registration is required. Dinner will be served.
URL:https://globalhealth.harvard.edu/event/pathways-to-global-health-with-dee-jordan/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/Pathways-to-Global-Health-with-Dee-Jordan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230913T170000
DTEND;TZID=America/Halifax:20230913T183000
DTSTAMP:20260413T085414
CREATED:20230908T105639Z
LAST-MODIFIED:20240419T154800Z
UID:10000213-1694624400-1694629800@globalhealth.harvard.edu
SUMMARY:Global Health Open House for Students
DESCRIPTION:Join us at the Harvard Global Health Institute’s (HGHI’s) Open House\, where you will: \n\nConnect with representatives from global health student groups and learn about their missions\, upcoming events\, and how to get involved\nLearn about undergraduate global health courses\, summer internships\, and research opportunities\nSpeak with HGHI Student Advisory Committee (SAC) peer advisors\nEnjoy light refreshments\, great conversations\, and the opportunity to connect with fellow Harvard undergraduate students with a shared interest in global health\n\nNo registration is required. Just stop by! \n*This event is for Harvard undergraduate students only.
URL:https://globalhealth.harvard.edu/event/global-health-open-house-for-students/
LOCATION:Harvard Global Health Institute\, 42 Church Street\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalhealth.harvard.edu/wp-content/uploads/2023/09/HGHI-Open-House-Sept-2023-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230612T120000
DTEND;TZID=America/Halifax:20230612T130000
DTSTAMP:20260413T085414
CREATED:20230530T133738Z
LAST-MODIFIED:20240419T154800Z
UID:10000212-1686571200-1686574800@globalhealth.harvard.edu
SUMMARY:Health Implications of Anti-LGBTIQ+ Stigma & Discrimination: Spotlight on Uganda
DESCRIPTION:Despite widespread condemnation\, on May 29th\, 2023 Uganda’s President signed the Anti-Homosexuality Act\, 2023 into law. While Uganda has passed anti-LGBTIQ+ legislation over the past several decades\, this bill is the most egregious and among the harshest anti-LGBTIQ+ laws in the world. Since the passage of the Act\, Ugandan\, regional\, and international organizations\, including the Global Fund to Fight AIDS\, TB and Malaria\, the Joint United Nations Programme on HIV/AIDS (UNAIDS)\, and The President’s Emergency Plan for AIDS Relief (PEPFAR)\, have rebuked it as a violation of human rights and a threat to the health of Ugandans. The Act will not only inflict direct harm on LGBTIQ+ Ugandans\, but will undermine public health campaigns\, most notably the HIV response\, by discouraging health seeking behaviors due to fear of punishment and marginalization.  \nOn June 12th\, the Harvard Global Health Institute and the Center for Global Health at Massachusetts General Hospital will host a webinar with local experts and advocates who will describe how the health and well being of Ugandans will be impacted by this legislation and how Uganda can forge a more inclusive path forward for all of its citizens.
URL:https://globalhealth.harvard.edu/event/health-implications-of-anti-lgbtiq-stigma-discrimination-spotlight-on-uganda/
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/05/Health-Implications-of-Anti-LGBTIQ-Stigma-Discrimination-Spotlight-on-Uganda-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230425T140000
DTEND;TZID=America/Halifax:20230425T150000
DTSTAMP:20260413T085414
CREATED:20230418T104725Z
LAST-MODIFIED:20240614T171550Z
UID:10000211-1682431200-1682434800@globalhealth.harvard.edu
SUMMARY:The Future of Public Health is Feminist
DESCRIPTION:
URL:https://globalhealth.harvard.edu/event/the-future-of-public-health-is-feminist/
LOCATION:HSPH Building 1 1208\, 665 Huntington Ave. Building 1\, room 1208\, Boston\, MA\, 02115
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230412T090000
DTEND;TZID=America/Halifax:20230412T160000
DTSTAMP:20260413T085414
CREATED:20230313T104218Z
LAST-MODIFIED:20240419T154800Z
UID:10000210-1681290000-1681315200@globalhealth.harvard.edu
SUMMARY:The Harvard Global Health Institute's Inaugural Global Health Symposium
DESCRIPTION:Harvard Global Health Institute is thrilled to announce that registration is now open for virtual attendance to our Inaugural Global Health Symposium! While in person capacity is limited\, we invite our longstanding global and Harvard-based community to join us virtually on April 12th\, 2023 from 9:00am to 4:00pm ET for a series of conversations centered around the theme “Global Health Equity through Community Engagement.” \nOur inaugural symposium will bring together experts from across the globe and from within Harvard University to highlight innovative\, community-driven approaches aimed at achieving global health equity. We will explore these approaches in the context of various disciplines\, including emerging infectious diseases\, human and reproductive rights\, planetary health\, anti-racism and decolonization\, and HIV equity. \nWe are thrilled to have over 25 global leaders in these respective fields joining us to engage in these critical discussions. Among this stellar collection of experts\, we are excited to share that Dr. Ahmed Ogwell Ouma\, Acting Director of Africa CDC and Dr. Soumya Swaminathan\, former Chief Scientist of the World Health Organization\, will be delivering keynote remarks. \nThank you for your interest in attending virtually on April 12th. A full recording of the symposium will be available on the HGHI website following the event. \nThe full agenda\, speaker list\, and registration details are available HERE.
URL:https://globalhealth.harvard.edu/event/the-harvard-global-health-institutes-inaugural-global-health-symposium/
ATTACH;FMTTYPE=image/jpeg:https://globalhealth.harvard.edu/wp-content/uploads/2023/03/save-the-date-4-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230323T130000
DTEND;TZID=America/Halifax:20230323T140000
DTSTAMP:20260413T085414
CREATED:20230306T203827Z
LAST-MODIFIED:20240614T171550Z
UID:10000209-1679576400-1679580000@globalhealth.harvard.edu
SUMMARY:Leveraging Improvement Science for Program Implementation
DESCRIPTION:  \n \nJoin Zoom meeting\nhttps://harvard.zoom.us/j/97881220923?pwd=QUN3b3FOUmxldVVZQXRqYmx6QzhvZz09 \nPassword: 768654 \nJoin by telephone (use any number to dial in)\n+1 312 626 6799\n+1 646 931 3860\n+1 929 436 2866\n+1 301 715 8592\n+1 305 224 1968\n+1 309 205 3325\n+1 689 278 1000\n+1 719 359 4580\n+1 253 205 0468\n+1 253 215 8782\n+1 346 248 7799\n+1 360 209 5623\n+1 386 347 5053\n+1 507 473 4847\n+1 564 217 2000\n+1 669 444 9171\n+1 669 900 6833 \nInternational numbers available: https://harvard.zoom.us/u/acf5B2yA1G \nOne tap mobile: +13126266799\,\,97881220923# US (Chicago)\nPassword: 768654 \nJoin by SIP conference room system\nMeeting ID: 978 8122 0923\n97881220923.768654@zoomcrc.com
URL:https://globalhealth.harvard.edu/event/leveraging-improvement-science-for-program-implementation/
LOCATION:HSPH Building 1 1208\, 665 Huntington Ave. Building 1\, room 1208\, Boston\, MA\, 02115
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2023/03/3.23-BB-flyer.png
END:VEVENT
END:VCALENDAR